Literature DB >> 10779778

RGS molecule expression in murine B lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines.

K Reif1, J G Cyster.   

Abstract

Ag-mediated changes in B lymphocyte migration are important for normal immune function, yet the mechanisms by which these changes occur are poorly defined. Because chemokines direct many lymphocyte movements, molecules that regulate signaling by G protein-coupled chemokine receptors are likely to participate in Ag receptor-induced changes in cell migration. In this study, we have investigated the expression pattern and activity in murine B cells of members of the regulators of G protein signaling (RGS) family of molecules. We present the sequence of mouse RGS1 and describe a novel short isoform of RGS3 that we term RGS3s. Following in vivo activation by Ag, B cells rapidly up-regulate expression of RGS1 and RGS2 while simultaneously decreasing expression of RGS3 and RGS14. Anergic hen egg lysozyme autoantigen-binding B cells are also shown to have slightly elevated RGS1 and RGS2 expression. CD40 signaling, by contrast, fails to cause rapid up-regulation of RGS1 or RGS2. Using a transient transfection approach in a mature B cell line, 2PK3, we demonstrate that RGS1 and RGS3s are effective inhibitors of chemotaxis toward the lymphoid tissue chemokines stromal cell-derived factor-1, B lymphocyte chemoattractant, and EBV-induced molecule 1 ligand chemokine, whereas RGS2 has a minimal effect on migration to these chemokines. Together these findings support the conclusion that Ag-mediated changes in RGS molecule expression are part of the mechanism by which Ag receptor signaling regulates B cell migration within lymphoid tissues. The findings also suggest important roles for additional G protein-mediated events in B cell activation and tolerance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10779778     DOI: 10.4049/jimmunol.164.9.4720

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  RGS18 is a myeloerythroid lineage-specific regulator of G-protein-signalling molecule highly expressed in megakaryocytes.

Authors:  D Yowe; N Weich; M Prabhudas; L Poisson; P Errada; R Kapeller; K Yu; L Faron; M Shen; J Cleary; T M Wilkie; C Gutierrez-Ramos; M R Hodge
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

2.  Abnormal B-cell responses to chemokines, disturbed plasma cell localization, and distorted immune tissue architecture in Rgs1-/- mice.

Authors:  Chantal Moratz; J Russell Hayman; Hua Gu; John H Kehrl
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

3.  Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma.

Authors:  Jacalyn Rosenblatt; Baldev Vasir; Lynne Uhl; Simona Blotta; Claire Macnamara; Poorvi Somaiya; Zekui Wu; Robin Joyce; James D Levine; Dilani Dombagoda; Yan Emily Yuan; Karen Francoeur; Donna Fitzgerald; Paul Richardson; Edie Weller; Kenneth Anderson; Donald Kufe; Nikhil Munshi; David Avigan
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

4.  Expression of regulator of G protein signalling proteins in natural killer cells, and their modulation by Ly49A and Ly49D.

Authors:  Lise Kveberg; James C Ryan; Bent Rolstad; Marit Inngjerdingen
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

5.  RGS3 controls T lymphocyte migration in a model of Th2-mediated airway inflammation.

Authors:  Jesse W Williams; Douglas Yau; Nan Sethakorn; Jacob Kach; Eleanor B Reed; Tamson V Moore; Judy Cannon; Xiaohua Jin; Heming Xing; Anthony J Muslin; Anne I Sperling; Nickolai O Dulin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-09-27       Impact factor: 5.464

6.  Changes in chemokines and chemokine receptor expression on tonsillar B cells upon Epstein-Barr virus infection.

Authors:  Barbro Ehlin-Henriksson; Wu Liang; Alberto Cagigi; Frida Mowafi; George Klein; Anna Nilsson
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

7.  DNA microarray gene expression profile of marginal zone versus follicular B cells and idiotype positive marginal zone B cells before and after immunization with Streptococcus pneumoniae.

Authors:  Nicholas W Kin; Dianna M Crawford; Jiabin Liu; Timothy W Behrens; John F Kearney
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

8.  Depletion of major pathogenic cells in asthma by targeting CRTh2.

Authors:  Tao Huang; Meredith Hazen; Yonglei Shang; Meijuan Zhou; Xiumin Wu; Donghong Yan; Zhonghua Lin; Margaret Solon; Elizabeth Luis; Hai Ngu; Yongchang Shi; Arna Katewa; David F Choy; Nandhini Ramamoorthi; Erick R Castellanos; Mercedesz Balazs; Min Xu; Wyne P Lee; Marissa L Matsumoto; Jian Payandeh; Joseph R Arron; Jo-Anne Hongo; Jianyong Wang; Isidro Hötzel; Cary D Austin; Karin Reif
Journal:  JCI Insight       Date:  2016-05-19

9.  Systematic comparison of gene expression between murine memory and naive B cells demonstrates that memory B cells have unique signaling capabilities.

Authors:  Mary M Tomayko; Shannon M Anderson; Catherine E Brayton; Saheli Sadanand; Natalie C Steinel; Timothy W Behrens; Mark J Shlomchik
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  Variations in Gnai2 and Rgs1 expression affect chemokine receptor signaling and the organization of secondary lymphoid organs.

Authors:  I Y Hwang; C Park; K A Harrision; N N Huang; J H Kehrl
Journal:  Genes Immun       Date:  2010-05-27       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.